Showing results (1081-1090 of 1,099) with videos related to

Sort By:
Pageof 110
The New England Journal of Medicine|May 29, 2026
First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion MutationsCaicun Zhou, Laurent Greillier, Geoffrey Liu, et al.
Plos One|September 9, 2008
Identification of PLCL1 gene for hip bone size variation in females in a genome-wide association studyYao-Zhong Liu, Scott G Wilson, Liang Wang, et al.
Ebiomedicine|March 26, 2025
Prevalence, genetic variations and clinical outcomes of BRAF-V600 mutated advanced NSCLC in China: a retrospective real-world multi-centre studyBo Jia, Shuo Wang, Fengyuan Zhang, et al.
The Lancet. Respiratory Medicine|December 1, 2025
Glecirasib plus sitneprotafib in patients with KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trialJia Zhong, Jun Zhao, Jianchun Duan, et al.
BMC Medicine|February 3, 2026
Early gestational prediction of spontaneous preterm birth using a validated three-protein serum biomarker panelQiong Luo, Juan Wei, Yun Ding, et al.
NPJ Digital Medicine|December 9, 2025
AI learning for pediatric right ventricular assessment: development and validation across multiple centersCharitha Reddy, Yi Yan, Min Qiu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
AI Learning for Pediatric Right Ventricular Assessment: Development and Validation Across Multiple CentersCharitha Reddy, Yi Yan, Min Qiu, et al.
Translational Lung Cancer Research|December 13, 2023
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced <i>EGFR</i>-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort studyDongming Zhang, Xiaoyan Liu, Fangfang Shen, et al.
Clinical Genetics|May 9, 2019
Congenital muscular dystrophies in ChinaLin Ge, Cheng Zhang, Zhaoxia Wang, et al.
The Lancet. Respiratory Medicine|December 15, 2023
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trialMengzhao Wang, Yun Fan, Meili Sun, et al.
Pageof 110